Xu Tan of Tsinghua University in China will harness the genome-editing power of the CRISPR-Cas9 system to eliminate latent HIV infection and provide a proof-of-concept for a potential cure for HIV infection.
Grant ID
TSING017
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False